発熱物質（パイロジェン）試験の世界市場：装置、サービス、キット、試薬...市場調査レポートについてご紹介

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 31)
4.1 Global Pyrogen Testing Market Overview (2016-2021)
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 35)
5.1 Introduction
5.1.1 Market Segmentation
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in Pharmaceutical and Biotechnology Industries
5.2.1.2 Increasing Number of New Drug Launches
5.2.1.3 Strong R&D Investments in the Life Sciences Industry
5.2.1.4 Increasing Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.5 High Incidence and Large Economic Burden of Chronic Diseases
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation to Act as A Major Barrier for New Entrants
5.2.3 Opportunities
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.3.2 Developing Countries Present Significant Opportunities for the Pyrogen Testing Market
5.2.4 Trends
5.2.4.1 Shift From Animal-Based Testing to in Vitro Testing

6 Industry Insights (Page No. – 44)
6.1 Introduction
6.2 Porter’s Five Forces Analysis
6.2.1 Threat of New Entrants
6.2.2 Threat of Substitutes
6.2.3 Bargaining Power of Buyers
6.2.4 Bargaining Power of Suppliers
6.2.5 Intensity of Rivalry
6.3 Strategic Benchmarking
6.3.1 Expansions
6.4 Supply Chain Analysis
6.4.1 Key Influencers

7 Pyrogen Testing Market, By Product (Page No. – 49)
7.1 Introduction
7.2 Kits and Reagents
7.3 Services
7.4 Instruments

8 Pyrogen Testing Market, By Application (Page No. – 56)
8.1 Introduction
8.2 Pharmaceutical and Biological Manufacturing
8.3 Medical Device Manufacturing
8.4 Other Applications

9 Pyrogen Testing Market, By Test Type (Page No. – 63)
9.1 Introduction
9.2 LAL Tests
9.2.1 Chromogenic Tests
9.2.2 Turbidimetric Tests
9.2.3 Gel Clot Tests
9.3 In Vitro Tests
9.4 Rabbit Tests

10 Pyrogen Testing Market, By Region (Page No. – 75)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
10.5.1 South America, Central America, and the Caribbean
10.5.2 Pacific and Oceania
10.5.3 Africa

11 Competitive Landscape (Page No. – 131)
11.1 Overview
11.2 Strategic Overview
11.3 Market Share Analysis
11.4 Competitive Situation and Trends
11.4.1 Expansions
11.4.2 Agreements, Collaborations, and Partnerships
11.4.3 Acquisitions
11.4.4 New Product Launches

12 Company Profiles (Page No. – 139)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Associates of Cape Cod, Inc.
12.3 Charles River Laboratories, Inc.
12.4 Lonza Group
12.5 Merck Kgaa
12.6 Ellab A/S
12.7 Genscript
12.8 Hyglos GmbH
12.9 Thermo Fisher Scientific, Inc.
12.10 Wako Chemicals Usa, Inc.
12.11 WUXI Pharmatech (Cayman) Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 165)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports